Medicare Enrolled
Dr. Svetlana Krasnokutsky, M.D.
Rheumatology · Purchase, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Krasnokutsky from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krasnokutsky?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Krasnokutsky
Dr. Svetlana Krasnokutsky is a rheumatology specialist in Purchase, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Krasnokutsky performed 136,838 Medicare services across 2,105 unique beneficiaries.
Between the years covered by Open Payments, Dr. Krasnokutsky received a total of $4,022 from 8 pharmaceutical and/or device companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Krasnokutsky is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NY
$4,022 industry payments
Medicare Practice Summary
Medicare Utilization ↗136,838
Medicare services
Top 2% in NY for rheumatology
2,105
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,202 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
63,400 | $4 | $20 |
| Tocilizumab injection (Actemra) | 54,937 | $5 | $11 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
8,730 | $34 | $130 |
| Denosumab injection (Prolia/Xgeva) | 5,161 | $18 | $43 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
894 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
428 | $109 | $332 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
397 | $8 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
354 | $124 | $927 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
310 | $13 | $88 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
277 | $8 | $29 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
271 | $10 | $58 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
258 | $4 | $17 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
256 | $5 | $25 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
141 | $1 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
130 | $158 | $446 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
122 | $27 | $141 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
77 | $27 | $157 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
72 | $29 | $200 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
65 | $7 | $206 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
51 | $3 | $15 |
| Rheumatoid factor level | 42 | $5 | $54 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
40 | $1 | $10 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
36 | $8 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $145 | $510 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $72 | $227 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
34 | $13 | $82 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
34 | $5 | $25 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
32 | $4 | $17 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
28 | $62 | $313 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
27 | $40 | $203 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
26 | $16 | $75 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
24 | $65 | $367 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
22 | $69 | $112 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
22 | $36 | $50 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
17 | $6 | $41 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
16 | $14 | $60 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
13 | $4 | $32 |
| New patient office visit, complex (60-74 min) | 12 | $186 | $642 |
| Hepatitis A antibody test A blood test that measures the level of antibodies to the hepatitis A virus in your body. This test helps determine if you have been exposed to the virus or if you have immunity from vaccination. |
11 | $12 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.7% high complexity
91.4% medium
1.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,022
Total received (2018-2024)
Avg $804/year across 5 years
Top 42% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
8
Companies
27
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,500 (62.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,522 (37.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$307
2023
$463
2022
$381
2019
$232
2018
$2,640
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$227
Novartis Pharmaceuticals Corporation
$80
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Flexion Therapeutics, Inc.
$2,500
ABBVIE INC.
$525
Novartis Pharmaceuticals Corporation
$254
Amgen Inc.
$250
AstraZeneca Pharmaceuticals LP
$125
Celgene Corporation
$124
Mallinckrodt Hospital Products Inc.
$123
AbbVie, Inc.
$121
Top 3 companies account for 81.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · COSENTYX · Enbrel · Humira · Otezla · RINVOQ · SAPHNELO · SKYRIZI · TAVNEOS · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (62%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Rheumatologists within 10 mi
276
Per 100K population
27.7
County median income
$118,411
Nearest hospital
WHITE PLAINS HOSPITAL CENTER
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Krasnokutsky is a mixed practice specialist, with above-average Medicare volume (top 2% in NY), with consulting-driven industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Krasnokutsky experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Krasnokutsky performed 63,400 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Krasnokutsky receive payments from pharmaceutical companies?
Yes. Dr. Krasnokutsky received a total of $4,022 from 8 companies across 27 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krasnokutsky's costs compare to other rheumatologists in Purchase?
Dr. Krasnokutsky's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krasnokutsky) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Purchase
Browse rheumatologists in Purchase ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NY
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NY
Which NY rheumatologists receive the most from drug and device companies.
By company
Flexion Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Flexion Therapeutics, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology